Lohman Technologies Selects Nassau Street Partners as Investment Bank to Lead $10M Capital Raise
- Lohman Tech
- 3 days ago
- 3 min read
Capital Infusion to accelerate commercialization and scale AI-Enabled Remote Cardiac Care Solution
MILWAUKEE, WI. (April 27, 2026) — Lohman Technologies announced today that it has selected Nassau Street Partners, a leading independent capital advisory firm with over $1 billion in aggregate transaction experience, as its investment banking partner to lead a $10 million capital raise. This strategic engagement will fuel the company’s commercial expansion of its AI enabled remote cardiac monitoring platform.
Lohman’s proprietary HomECG+ platform delivers FDA-cleared clinical-grade ECG technology, explainable AI analytics, and cloud-based care coordination to support continuity of cardiac care. Building on the success of AfibAlert — the first FDA-cleared handheld atrial fibrillation detection device — Lohman continues to lead in portable cardiac diagnostics and health equity.
"The post-discharge period remains one of the biggest gaps in cardiac care, and this funding will enable us to reach more patients and providers with reliable, technology-barrier-free connectivity.”
-- Jason Dvorak, President of Lohman Technologies
“This partnership with Nassau Street Partners marks a significant milestone as we scale our commercial efforts,” said Jason Dvorak, President of Lohman Technologies. “Their proven expertise in capital markets advisory and a deep network of institutional and family office investors will help us secure the resources needed to expand access to our physician-directed remote monitoring solutions. The post-discharge period remains one of the biggest gaps in cardiac care, and this funding will enable us to reach more patients and providers with reliable, technology-barrier-free connectivity.”
Nassau Street Partners Director Saul Friend shared: "We are proud to partner with Lohman Technologies and their Board of Directors. Our goal is to bring this opportunity to our global network of family offices and high net worth investors to support the growth of this to Lohman’s purposeful and needed mission. Remote cardiac monitoring is one of the most compelling intersections of clinical need and commercial opportunity we have seen in the current market. Lohman Technologies has done what most companies at this stage have not: built a genuinely differentiated, FDA cleared platform with contracted revenue and demand that outpaces their current capacity to supply. Our job is simply to put the right capital behind a team and technology that are already working.”
Craig Schiefelbein, Chairman, added, “Selecting a high-caliber partner like Nassau Street Partners is critical as we execute our growth strategy. Their focus on delivering optimal outcomes for clients, combined with extensive experience raising capital for innovative healthcare companies, aligns perfectly with our mission to deliver proactive, accessible, and longitudinal cardiac care. This raise will support key commercial initiatives, including broader market penetration, strategic partnerships with enterprise health systems and RPM providers, and continued innovation in remote patient monitoring.”
Nassau Street Partners brings 75+ years of combined capital markets experience and a global network of family offices and institutional investors. The firm is known for providing tailored, conflict-free advisory services in capital raising, with a track record of helping growth-stage companies achieve their strategic objectives.
The $10 million raise will primarily support commercialization efforts for the HomECG+ platform, including expanded sales and marketing, operational scaling, and enhancements that further improve patient outcomes and health equity by eliminating barriers such as smartphone or WiFi dependency.
About Lohman Technologies
Lohman’s patented solution, HomECG+, offers a direct connection between the patient and their healthcare providers, eliminating the need for a smartphone or WIFI technology. This not only enhances efficiency but also expands access to cardiac monitoring services. Visit www.homecg.com for more information.
